Equity Overview
Price & Market Data
Price: $0.0039
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $517,274
Daily Volume: 0
Details
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.